Sex-specific T cell exhaustion drives differential immune responses in glioblastoma
暂无分享,去创建一个
M. Ahluwalia | M. McGraw | A. Valujskikh | R. Fairchild | J. Lathia | Defne Bayik | Matthew M. Grabowski | Dionysios C. Watson | Amar B. Desai | Adam J. Lauko | Daniel J. Silver | D. Kish | M. Nicosia | Juyeun Lee | W. Goodman | Scott J. Cameron | Cathy Li | S. Johnson | Hideo Okada | A. Lauko | D. Bayik
[1] R. Cui,et al. Brain–immune interaction mechanisms: Implications for cognitive dysfunction in psychiatric disorders , 2022, Cell proliferation.
[2] G. Giaccone,et al. Sex and cancer immunotherapy: Current understanding and challenges. , 2022, Cancer cell.
[3] Lingling Wu,et al. Androgen receptor-mediated CD8+ T cell stemness programs drive sex differences in antitumor immunity. , 2022, Immunity.
[4] J. C. Eickhoff,et al. Sexual dimorphism of the immune system predicts clinical outcomes in glioblastoma immunotherapy: A systematic review and meta-analysis , 2022, Neuro-oncology advances.
[5] Ansuman T. Satpathy,et al. Epigenetic regulation of T cell exhaustion , 2022, Nature Immunology.
[6] A. Arnold,et al. Sex differences in NK cells mediated by the X-linked epigenetic regulator UTX , 2022, bioRxiv.
[7] Lei Zhou,et al. Androgen conspires with the CD8+ T cell exhaustion program and contributes to sex bias in cancer , 2022, Science Immunology.
[8] Susan E. Murray,et al. Androgen receptor activity in T cells limits checkpoint blockade efficacy , 2022, Nature.
[9] T. Cloughesy,et al. Nivolumab plus radiotherapy with or without temozolomide in newly diagnosed glioblastoma: Results from exploratory phase I cohorts of CheckMate 143 , 2022, Neuro-oncology advances.
[10] Zachary L. Skidmore,et al. Characterization of the Genomic and Immunologic Diversity of Malignant Brain Tumors through Multisector Analysis , 2021, Cancer discovery.
[11] G. Giaccone,et al. Sex-based dimorphism of anticancer immune response and molecular mechanisms of immune evasion , 2021, Clinical Cancer Research.
[12] S. Klein,et al. Sex disparities matter in cancer development and therapy , 2021, Nature Reviews Cancer.
[13] A. Arnold,et al. X chromosome escapee genes are involved in ischemic sexual dimorphism through epigenetic modification of inflammatory signals , 2021, Journal of neuroinflammation.
[14] Aaron J. Johnson,et al. Brain cancer induces systemic immunosuppression through release of non-steroid soluble mediators. , 2020, Brain : a journal of neurology.
[15] S. Erkeland,et al. Rapid in vitro generation of bona fide exhausted CD8+ T cells is accompanied by Tcf7 promotor methylation , 2020, PLoS pathogens.
[16] F. Hodi,et al. Abstract A83: Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade , 2020, Poster Presentations - Proffered Abstracts.
[17] I. Meester,et al. SeXY chromosomes and the immune system: reflections after a comparative study , 2020, Biology of Sex Differences.
[18] S. Freedland,et al. Association of Patient Sex With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Advanced Cancers: A Systematic Review and Meta-analysis , 2019, JAMA oncology.
[19] F. Hodi,et al. Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade , 2019, Nature Immunology.
[20] Daniel E. Speiser,et al. Intratumoral Tcf1+PD‐1+CD8+ T Cells with Stem‐like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy , 2019, Immunity.
[21] P. Wen,et al. Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma , 2018, Nature Medicine.
[22] B. Nahed,et al. Sequestration of T-cells in bone marrow in the setting of glioblastoma and other intracranial tumors , 2018, Nature Medicine.
[23] C. Bettegowda,et al. Current state of immunotherapy for glioblastoma , 2018, Nature Reviews Clinical Oncology.
[24] S. Chanock,et al. Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21 , 2018, Scientific Reports.
[25] Jill S Barnholtz-Sloan,et al. Females have the survival advantage in glioblastoma. , 2018, Neuro-oncology.
[26] D. Bigner,et al. T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma , 2018, Clinical Cancer Research.
[27] Jingqin Luo,et al. Sexual dimorphism in glioma glycolysis underlies sex differences in survival. , 2017, JCI insight.
[28] A. Daud,et al. Partially exhausted tumor-infiltrating lymphocytes predict response to combination immunotherapy. , 2017, JCI insight.
[29] Ava C. Carter,et al. Free-living human cells reconfigure their chromosomes in the evolution back to uni-cellularity , 2017, bioRxiv.
[30] D. Quail,et al. The Microenvironmental Landscape of Brain Tumors. , 2017, Cancer cell.
[31] S. Klein,et al. Sex differences in immune responses , 2016, Nature Reviews Immunology.
[32] C. Libert,et al. The X chromosome in immune functions: when a chromosome makes the difference , 2010, Nature Reviews Immunology.
[33] Xiaowei Wang,et al. PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification , 2009, Nucleic Acids Res..